Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bausch Health Announces Participation In Upcoming Investor Conferences

T.BHC

Canada NewsWire

LAVAL, Quebec , May 6, 2021 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in multiple upcoming investor conferences.

Joseph C. Papa , chairman and chief executive officer; Sam Eldessouky , senior vice president and corporate controller; and Arthur J. Shannon , senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Bank of America Merrill Lynch Global Healthcare Conference on May 12, 2021 at 11:00 a.m. ET .

Paul S. Herendeen , executive vice president and chief financial officer; Sam Eldessouky , senior vice president and corporate controller; William Woodfield , senior vice president and treasurer; and Arthur J. Shannon , senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Goldman Sachs Leveraged Finance Conference on May 17, 2021 , at 1:10 p.m. ET and the Barclays High Yield Bond and Syndicated Loan Conference on May 25, 2021 at 12:45 p.m. ET .

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2021 .

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com .

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

arthur.shannon@bauschhealth.com

lainie.keller@bauschhealth.com

(514) 856-3855

(908) 927-1198

(877) 281-6642 (toll free)


Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-301284956.html

SOURCE Bausch Health Companies Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2021/06/c4694.html



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today